Founded in 1994 as a spinout from the University of Calgary, SemBioSys Genetics, is a biotechnology company engaged in the development and commercialization of protein pharmaceutical and non-pharmaceutical products. Their proprietary protein production system addresses major commercialization challenges associated with the production of recombinant proteins; overcoming limitations in scale, capital and production costs. SemBioSys' proprietary technology harnesses the natural ability of seeds to produce, extract and purify proteins in large quantities and at low cost, while dramatically reducing downstream purification costs. It is unique as the only transgenic technology that addresses protein recovery and purification simultaneously with bulk protein production. SemBioSys' technology is compatible with simple peptides, polypeptides and complex proteins such as antibodies.